Related Experiment Videos

[Dyslipidaemia and diabetes mellitus]

J Ducobu1

  • 1CHU Tivoli, La Louvière. jean.ducobu@chu-tivoli.be

Revue Medicale De Liege
|July 23, 2005
PubMed

Insights

Diabetic patients face major cardiovascular risks due to abnormal lipid patterns. European guidelines recommend stricter lipid targets and lifestyle changes, with statins or fibrates as primary treatments.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Syndrome

Context:

  • Cardiovascular diseases (CVD) are a primary complication in diabetes mellitus.
  • Diabetic dyslipidemia is characterized by high triglycerides, low HDL cholesterol, and increased small dense LDL cholesterol.
  • Current treatment strategies follow European Guidelines emphasizing global risk evaluation.

Purpose:

  • To outline the lipid patterns in diabetic patients.
  • To discuss the European Guidelines for managing dyslipidemia in diabetes.
  • To identify the preferred pharmacological treatments for diabetic dyslipidemia.

Summary:

  • The lipid profile in diabetes typically involves hypertriglyceridemia, hypoalphalipoproteinemia, and elevated levels of small, dense low-density lipoprotein (LDL) particles.
  • European guidelines advocate for a comprehensive risk assessment and more stringent lipid targets for individuals with diabetes compared to those without.
  • Lifestyle modifications and risk factor control are foundational, followed by pharmacotherapy, with statins and fibrates being the mainstays.

Impact:

  • Provides a concise overview of lipid management in diabetic patients.
  • Highlights the importance of adhering to European Guidelines for cardiovascular risk reduction.
  • Emphasizes the role of statins and fibrates, particularly fibrates in patients with diabetes and metabolic syndrome.

Related Concept Videos

Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...